دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Intercontinental Deceased-donor Kidney Transplantation in Dutch Antilleans: Favorable Outcomes Despite Prolonged Ischemia.
Houtzager, Julia H.E. MSc 1; Peters-Sengers, Hessel MSc, PhD 2; Ajubi, Nouaf V. MD 3; Develter, Willem MD 3; Kock, Romeo MD 4; Idu, Mirza M. MD, PhD 1; van der Weerd, Neelke C. MD, PhD 2; Lardy, Neubury MSc, PhD 5; Homan van der Heijde, Jaap J. MD, PhD 2; van der Pant, Karlijn A. MD 2; Choudhry, Zaheeb A. MD 2; Bemelman, Frederike J. MD, PhD 2
doi : 10.1097/TP.0000000000004486
Volume 107(5) pgs. 1005-1212,e125-e158 May 2023
Extracorporeal Photopheresis Suppresses Transplant Fibrosis by Inducing Decorin Expression in Alveolar Macrophages.
Hutchinson, James A. MD, PhD 1; Benazzo, Alberto MD, PhD 2,3
A Multicenter Survey Study of Lung Transplant Program Staffing.
Trindade, Anil J. MD 1,2; Chapin, Kaitlyn C. MSN 2; Gannon, Whitney D. MSN 1; Erasmus, David B. MD 1,2; Shaver, Ciara M. MD, PhD 1,2
Metabolomic Analysis, Perfusate Composition, and Pseudo-physiology of the Isolated Liver During Ex Situ Normothermic Machine Perfusion.
Hessheimer, Amelia J. MD, PhD 1; Vengohechea, Jordi BS 1; Fondevila, Constantino MD, PhD 1
Removing Barriers and Mitigating Risk: The Case for Crossing Donor-specific Antibodies in Lung Transplantation With the Use of Perioperative Desensitization.
Aversa, Meghan MD, MSc 1
IL-21-producing Alloreactive T Cells Expand in Parallel to Donor-specific Antibodies.
Issa, Fadi DPhil 1; Cross, Amy R. PhD 1
Prevention of Posttransplant Diabetes: A Complex Problem Without a Simple Solution.
Oveyssi, Justin DO 1; Huang, Edmund MD 1
Fixed but Feasible: New Opportunities for Molecular Diagnostics in Transplantation.
Keung, Karen L. MBBS, PhD 1; Li, Jennifer S.Y. MBBS 2
Cutting the Ice in Donor Heart Preservation.
Macdonald, Peter S. MD, PhD, FRACP 1,2,3
On a Long and Winding Road: Alloantibodies in Organ Transplantation.
Bohmig, Georg A. MD 1; Halloran, Philip F. MD, PhD 2; Feucht, Helmut E. MD 3
doi : 10.1097/TP.0000000000004550
AB Today we know that both the humoral and the cellular arm of the immune system are engaged in severe immunological challenges. A close interaction between B and T cells can be observed in most "natural" challenges, including infections, malignancies, and autoimmune diseases.
The Histological Spectrum and Clinical Significance of T Cell-mediated Rejection of Kidney Allografts.
Filippone, Edward J. MD 1; Farber, John L. MD 2
doi : 10.1097/TP.0000000000004438
AB T cell-mediated rejection (TCMR) remains a significant cause of long-term kidney allograft loss, either indirectly through induction of donor-specific anti-HLA alloantibodies or directly through chronic active TCMR.
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance.
Sprangers, Ben MD, PhD 1,2; Hegenbart, Ute MD, PhD 3; Wetzels, Jack F.M. MD, PhD 4
doi : 10.1097/TP.0000000000004443
AB Monoclonal gammopathy of renal significance (MGRS) defines disorders characterized by direct or indirect kidney injury caused by a monoclonal immunoglobulin produced by a B-cell or plasma-cell clone that does not meet current hematologic criteria for therapy.
The Reparative Roles of IL-33.
Bou Saba, Johnny MD 1,2; Turnquist, He[Combining Macron]th R. PhD 1,2,3,4
doi : 10.1097/TP.0000000000004447
AB When discovered in the early 2000s, interleukin-33 (IL-33) was characterized as a potent driver of type 2 immunity and implicated in parasite clearance, as well as asthma, allergy, and lung fibrosis.
Estimation of Sensitization Status in Renal Transplant Recipients by Assessing Indirect Pathway CD4+ T Cell Response to Donor Cell-pulsed Dendritic Cell.
Kenta, Iwasaki PhD 1; Toshihide, Tomosugi MD, PhD 2,3; Takashi, Sekiya PhD 4; Shintaro, Sakamoto PhD 5; Yuko, Miwa PhD 1; Manabu, Okada MD, PhD 2; Takahisa, Hiramitsu MD, PhD 2; Norihiko, Goto MD, PhD 2; Shunji, Narumi MD, PhD 2; Yoshihiko, Watarai MD, PhD 2; Mai, Okumura MD 3; Satoshi, Ashimine MD, PhD 3; Kohei, Ishiyama MD, PhD 3; Ezzelarab, Mohamed B. MD, PhD 6; Takaaki, Kobayashi MD, PhD 3
doi : 10.1097/TP.0000000000004491
AB Background. Generation of donor-specific human leukocyte antigen antibody (DSA) via indirect allorecognition is detrimental to long-term survival of transplant organs.
Modulation of Monocyte Response by MicroRNA-15b/106a/374a During Antibody-mediated Rejection in Kidney Transplantation.
Tinel, Claire MD, PhD 1,2,3; Lamarthee, Baptiste PhD 2,3; Gazut, Stephane MSc 4; Van Loon, Elisabet MD, PhD 5,6; Von Tokarski, Florent MSc 2; Benon, Aurelien MSc 2; Sauvaget, Virginia MSc 2; Garcia-Paredes, Victor MSc 7; Menager, Mickael PhD 7; Morin, Lise MSc 8; Aouni, Laila MSc 8; Cagnard, Nicolas MSc 9; Rabant, Marion MD, PhD 2,10; Legendre, Christophe MD, PhD 8; Terzi, Fabiola MD, PhD 2; Essig, Marie MD, PhD 11; Gwinner, Wilfried MD, PhD 12; Naesens, Maarten MD, PhD 5,6; Marquet, Pierre MD, PhD 13; Anglicheau, Dany MD, PhD 2,8
doi : 10.1097/TP.0000000000004393
AB Background. Increasing evidence suggest that microRNAs are involved in the physiopathology of acute or chronic renal disease. In kidney transplantation, as key regulators of cellular homeostasis, microRNAs may be involved in the regulation of immune cell function and the allograft response.
Relating Molecular T Cell-mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis.
Madill-Thomsen, Katelynn S. PhD 1; Bohmig, Georg A. MD 2; Bromberg, Jonathan MD, PhD 3; Einecke, Gunilla MD, PhD 4; Eskandary, Farsad MD, PhD 2; Gupta, Gaurav MD 5; Myslak, Marek MD, PhD 6; Viklicky, Ondrej MD, PhD 7; Perkowska-Ptasinska, Agnieszka MD, PhD 8; Solez, Kim MD 9; Halloran, Philip F. MD, PhD 1,10; the INTERCOMEX Investigators
doi : 10.1097/TP.0000000000004396
AB Background. We studied the variation in molecular T cell-mediated rejection (TCMR) activity in kidney transplant indication biopsies and its relationship with histologic lesions (particularly tubulitis and atrophy-fibrosis) and time posttransplant.
Biliary Complications After Liver Transplantation in the United States: Changing Trends and Economic Implications.
Manay, Priyadarshini MBBS 1; Seth, Abhinav MBBS 1; Jackson, Kyle MD 2; Lentine, Krista L. MD, PhD 3; Schnitzler, Mark A. PhD 3; Xiao, Huiling MS 3; Segev, Dorry L. MD, PhD 2; Axelrod, David A. MD, MBA 1
doi : 10.1097/TP.0000000000004528
Biliary complications (BCs) continue to impact patient and graft survival after liver transplant (LT), despite improvements in organ preservation, surgical technique, and posttransplant care. Real-world evidence provides a national estimate of the incidence of BC after LT, implications for patient and graft outcomes, and attributable cost not available in transplant registry data.
Metabolomics Differences of the Donor Livers Between In Situ and Ex Situ Conditions During Ischemia-free Liver Transplantation.
Guo, Zhiyong MD, PhD 1,2,3,4; Zhan, Liqiang MD 1,2,3; Gao, Ningxin MD 1,2,3; Zhang, Zhiheng MD 5; Huang, Shanzhou MD 1,2,3; Wang, Linhe MD 1,2,3; Zhu, Caihui MD 1,2,3; Jia, Zehua MD 1,2,3; Yin, Meixian MD 1,2,3; Li, Fangcong MD 1,2,3; Chen, Shirui MD 1,2,3; Luo, Tao MD 1,2,3; Liu, Yao MD 1,2,3; Jia, Yu MD 1,2,3; Wang, Tielong MD 1,2,3; Xu, Jinghong MD 1,2,3; Li, Yuexin MD 6; Zhu, Yifan MD 7; Chen, Yichao MD 6; Yu, Chuhan 7; Tang, Yunhua MD, PhD 1,2,3; Zhao, Qiang MD, PhD 1,2,3; Wang, Dongping MD, PhD 1,2,3; He, Xiaoshun MD, PhD 1,2,3
doi : 10.1097/TP.0000000000004529
AB Background. Ischemia-free liver transplantation (IFLT) has been innovated to avoid graft ischemia during organ procurement, preservation, and implantation. However, the metabolism activity of the donor livers between in the in situ and ex situ normothermic machine perfusion (NMP) conditions, and between standard criteria donor and extend criteria donor remains unknown.
Examining the Role for Donor-specific Antibody Testing in Simultaneous Liver-kidney Transplantation: A Single-center Analysis of Outcomes.
Das, Anushka BS 1; Rocque, Brittany MD[low single comma quotation mark] MSc 1,2; Remulla, Daphne MD 1; Raza, Muhammad MD 1; Barbetta, Arianna MD 1,2; Bangerth, Sarah MS 2; Goldbeck, Cameron MS 2; Maw, Thin Thin MBBS 1,3; Kim, Jim MD 1,2; Kwon, Yong MD 1,2; Emamaullee, Juliet MD, PhD 1,2
doi : 10.1097/TP.0000000000004404
AB Background. Simultaneous liver-kidney transplantation (SLKT) is increasingly used for patients with concurrent end-stage liver and renal disease. Emerging evidence suggests that simultaneous liver transplant can provide a tolerogenic benefit to multiorgan transplant recipients.
Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study.
Callaghan, Chris J. PhD 1; Curtis, Rebecca M.K. BSc 1; Mumford, Lisa MSc 1; Whitaker, Heather PhD 2; Pettigrew, Gavin MD 1; Gardiner, Dale FFICM 1; Marson, Lorna MD 1; Thorburn, Douglas FRCP 1; White, Steven FRCS 1; Parmar, Jas FRCP 1; Ushiro-Lumb, Ines FRCP 1; Manas, Derek FRCS 1; Ravanan, Rommel FRCP 1; on behalf of the NHS Blood and Transplant Organ and Tissue Donation and Transplantation Clinical Team
doi : 10.1097/TP.0000000000004535
AB Background. The effectiveness of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) B.1.1.529 Omicron variant in immunosuppressed solid organ and islet transplant (SOT) recipients is unclear.
Kidney Transplant and Dialysis Patients Remain at Increased Risk for Succumbing to COVID-19.
Weiss, Anne MSc 1,2; Hendrickx, Rodinde PhD 3; Stensgaard, Eva MSc 3; Jellingso, Mads MSc 3; Sommer, Morten O.A. PhD 2,3
doi : 10.1097/TP.0000000000004462
AB Background. Immunocompromised patients have been at an increased risk of succumbing to coronavirus disease 2019 (COVID-19) since the beginning of the pandemic.
Immune Response to COVID-19 mRNA Vaccination in Previous Nonresponder Kidney Transplant Recipients After Short-term Withdrawal of Mycophenolic Acid 1 and 3 Months After an Additional Vaccine Dose.
Kuhn, Tessa 1; Speer, Claudius MD 1,2; Morath, Christian MD 1; Bartenschlager, Marie 3; Kim, Heeyoung PhD 3; Beimler, Jorg MD 1; Buylaert, Mirabel MD 1; Nusshag, Christian MD 1; Kalble, Florian MD 1; Reineke, Marvin 1; Tollner, Maximilian 1; Klein, Katrin MD 1; Blank, Antje MD 4,5; Parthe, Sylvia MD 6; Schnitzler, Paul PhD 6; Zeier, Martin MD 1; Susal, Caner MD 7; Bartenschlager, Ralf PhD 3,5,8; Tran, Thuong Hien MD 9; Schaier, Matthias MD 1; Benning, Louise MD 1
doi : 10.1097/TP.0000000000004516
AB Background. The impaired immune response to coronavirus disease 2019 (COVID-19) vaccination in kidney transplant recipients (KTRs) leads to an urgent need for adapted immunization strategies.
Outcomes of Heart Transplantation Using a Temperature-controlled Hypothermic Storage System.
Zhu, Yuanjia MD, MS 1; Shudo, Yasuhiro MD, PhD 1; He, Hao PhD 1; Kim, Joo Young PA-C 1; Elde, Stefan MD 1; Williams, Kiah M. MD 1; Walsh, Sabrina K. BS 1; Koyano, Tiffany K. BS 1; Guenthart, Brandon MD 1; Woo, Y. Joseph MD 1
doi : 10.1097/TP.0000000000004416
The SherpaPak Cardiac Transport System is a novel technology that provides stable, optimal hypothermic control during organ transport. The objectives of this study were to describe our experience using the SherpaPak system and to compare outcomes after heart transplantation after using SherpaPak versus the conventional static cold storage method (non-SherpaPak).
Is Exclusion of Coronary Artery Disease in the Kidney Allocation System Preventing Optimal Longevity Matching?.
Tandukar, Srijan MD 1
doi : 10.1097/TP.0000000000004392
Coronary artery disease (CAD) in a kidney transplant candidate is an important predictor of posttransplant mortality. It is not known how the exclusion of CAD in the kidney allocation system has impacted its goal of longevity matching.
Safety of Crossing Donor-specific Antibodies in Lung Transplantation.
Wang, Melissa MD 1; Campbell, Patricia MBChB 1,2; Lien, Dale C. MD 1; Varughese, Rhea MD 1; Weinkauf, Justin MD 1; Nagendran, Jayan MD, PhD 3; Hirji, Alim MD 1; Li, David BSc 1; Halloran, Kieran MD 1
doi : 10.1097/TP.0000000000004413
AB Background. Donor-specific antibodies (DSAs) have been associated with antibody-mediated rejection, chronic lung allograft dysfunction (CLAD), and increased mortality in lung transplant recipients.
Sitagliptin Versus Placebo to Reduce the Incidence and Severity of Posttransplant Diabetes Mellitus After Kidney Transplantation-A Single-center, Randomized, Double-blind Controlled Trial.
Delos Santos, Rowena B. MD 1; Hagopian, Jennifer C. PharmD 2; Chen, Ling PhD 3; Ramakrishnan, Madhuri MD 4; Wijeweera, Helen CNP 1; Klein, Christina L. MD 5; Brennan, Daniel C. MD 6
doi : 10.1097/TP.0000000000004373
Postkidney transplant diabetes mellitus (PTDM) affects cardiovascular, allograft, and recipient health. We tested whether early intervention with sitagliptin for hyperglycemia (blood glucose >200 mg/dL) within the first week of transplant and discontinued at 3 mo could prevent development of PTDM in patients without preexisting diabetes.
Utility of Banff Human Organ Transplant Gene Panel in Human Kidney Transplant Biopsies.
Smith, Rex N. MD 1,2; Rosales, Ivy A. MD 1,2; Tomaszewski, Kristen T. MD 1,2; Mahowald, Grace T. MD 1; Araujo-Medina, Milagros BA 1; Acheampong, Ellen BA 1; Bruce, Amy BA 1; Rios, Andrea BA 1; Otsuka, Takuya MD 3; Tsuji, Takahiro MD 4; Hotta, Kiyohiko MD 5; Colvin, Robert MD 1,2
doi : 10.1097/TP.0000000000004389
Microarray transcript analysis of human renal transplantation biopsies has successfully identified the many patterns of graft rejection. To evaluate an alternative, this report tests whether gene expression from the Banff Human Organ Transplant (B-HOT) probe set panel, derived from validated microarrays, can identify the relevant allograft diagnoses directly from archival human renal transplant formalin-fixed paraffin-embedded biopsies.
Nirmatrelvir/ritonavir Use With Tacrolimus in Lung Transplant Recipients: A Single-center Case Series.
Dewey, Katherine W. PharmD, BCPS 1; Yen, Bo PharmD, BCPS 1; Lazo, Jose PharmD, BCTXP, BCPS 1; Seijo, Leslie MD 2; Jariwala, Ripal PharmD, BCIDP, AAHIVP 1; Shah, Rupal J. MD, MS 2; Quan, David PharmD, BCTXP, BCPS 1; Carpenter, Bethanne PharmD, BCPS, BCIDP 1; Paul Singer, Jonathan MD, MS 2; Breen, Karen RN, MSN 2; Hays, Steven MD 2; Florez, Rebecca PharmD 1
doi : 10.1097/TP.0000000000004394
AB Background. Limited data and guidelines exist for using nirmatrelvir/ritonavir in solid organ transplant recipients stabilized on tacrolimus for the treatment of mild-to-moderate coronavirus disease.
Kidney-transplanted Adolescents-Nonadherence and Graft Outcomes During the Transition Phase: A Nationwide Analysis, 2000-2020.
Kindem, Ingvild A. MD 1,2,3; Bjerre, Anna MD, PhD 1,2; Hammarstrom, Clara MD 4; Naper, Christian MD 5; Midtvedt, Karsten MD, PhD 3; Asberg, Anders PhD 3,6,7
Expanding Heart Donor Pool With a Broken Heart: Cardiac Transplant From Donor Following Circulatory Death With Takotsubo Syndrome.
Groba Marco, Maria del Val MD 1,2; Galvan Ruiz, Mario MD 2; Cabrera Santana, Miriam MD 3,4; Romero Lujan, Jose Luis MD 4; Portela Torron, Francisco MD 2,5; Santana Ortega, Luis MD 6; Fernandez de Sanmamed Giron, Miguel MD 2; Caballero Dorta, Eduardo Jose PhD 1,2; Garcia Quintana, Antonio MD 2
First Report of Immunoglobulin G4-related Hepatic Inflammatory Pseudotumor in Transplanted Liver.
Wang, Xintong MD 1; El Jabbour, Tony MD 2; Chahal, Daljeet MD 3; Odin, Joseph A. MD, PhD 3; Crismale, James MD 3; Taouli, Bachir MD, MHA 4; Thung, Swan N. MD 1; Ward, Stephen C. MD, PhD 1
Access to the Kidney Transplant Waitlist for People With HIV.
Shelton, Brittany A. DrPH 1,2,3; MacLennan, Paul A. PhD 2; Becker, David J. PhD 3; Sen, Bisakha PhD 3; Budhwani, Henna PhD, MPH 4; Locke, Jayme E. MD, MPH 2
Pretransplant C-peptide Levels and Pancreas Transplant Outcomes: Risk and Reward.
Stratta, Robert J. MD 1; Jay, Colleen L. MD 1
